博士論文

Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice

Icons representing 博士論文

Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice

Call No. (NDL)
UT51-2014-A850
Bibliographic ID of National Diet Library
025731121
Material type
博士論文
Author
Kinya Inoue [著]
Publisher
[Kinya Inoue]
Publication date
[2012]
Material Format
Paper
Capacity, size, etc.
4冊 (副論文・参考論文とも)
Name of awarding university/degree
久留米大学,博士(医学)
View All

Notes on use

Note (General):

博士論文

Accompanying material:

要旨 1枚

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type
博士論文
Author/Editor
Kinya Inoue [著]
Author Heading
井上, 欣哉 イノウエ, キンヤ
Publication, Distribution, etc.
Publication Date
[2012]
Publication Date (W3CDTF)
2012
Extent
4冊 (副論文・参考論文とも)
Accompanying material
要旨 1枚
Alternative Title
VEGF receptor2とEGF receptor阻害剤であるVandetanibはマウスの肝臓癌増殖を抑制し、予後を改善する VEGF receptor 2 ト EGF receptor ソガイザイ デ アル Vandetanib ワ マウス ノ カンゾウ ガン ゾウショク オ ヨクセイシ ヨゴ オ カイゼンスル